Level 2 resilience Sub-factors supporting risk mapping, modeling, planning and control (risk MMPC)
| Level 1 resilience sub-factors | Level 2 resilience sub-factors |
|---|---|
| Risk MMPC – product flow | Mapping of input, manufacturing, cold chain and vaccine supply bottlenecks |
| Supply strategies to minimize stockouts | |
| Use of advanced modeling technologies to identify system risks | |
| Identification and prioritization of security and other threats Capacity sharing and production incentivizing strategies | |
| Use of foreign manufactured vaccines to increase supply | |
| Implementation of regulatory standards and compliance requirements | |
| Immunization of health-care workers to minimize illness | |
| Guaranteed vaccine supply arrangements | |
| Strategic location of inventory | |
| Transportation assessments and validations | |
| Selection of suppliers based on technical and compliance capabilities | |
| Risk MMPC – financial flow | Investment in capacity at risk by private sector, government, international organizations |
| Use of contractual terms to mitigate financial risk | |
| Risk MMPC – information flow | Mapping and control of cyber risks |
| Use of electronic marketplaces to rapidly identify input suppliers | |
| Information dissemination to reduce vaccine hesitancy | |
| Tracking of vaccine serialization and adverse effects following immunization | |
| Use of monitoring and alert systems to identify risks and bottlenecks | |
| Availability of back up equipment for monitoring cold chain temperatures | |
| Risk MMPC – vaccine recipient flow | Strategies to reduce vaccine hesitancy |
| Risk MMPC – knowledge flow | Strategies for transferring technology |
| Minimization of liability associated with technology use and licensure | |
| Risk MMPC – skilled worker flow | Establishment of regulatory training center |
| Establishment of logistics training center | |
| Risk MMPC – waste flow | Strategies to minimize waste |
| Ability to trace vaccine waste resulting from criminal activity |
| Level 2 resilience sub-factors | |
|---|---|
| Mapping of input, manufacturing, cold chain and vaccine supply bottlenecks | |
| Supply strategies to minimize stockouts | |
| Use of advanced modeling technologies to identify system risks | |
| Identification and prioritization of security and other threats | |
| Use of foreign manufactured vaccines to increase supply | |
| Implementation of regulatory standards and compliance requirements | |
| Immunization of health-care workers to minimize illness | |
| Guaranteed vaccine supply arrangements | |
| Strategic location of inventory | |
| Transportation assessments and validations | |
| Selection of suppliers based on technical and compliance capabilities | |
| Investment in capacity at risk by private sector, government, international organizations | |
| Use of contractual terms to mitigate financial risk | |
| Mapping and control of cyber risks | |
| Use of electronic marketplaces to rapidly identify input suppliers | |
| Information dissemination to reduce vaccine hesitancy | |
| Tracking of vaccine serialization and adverse effects following immunization | |
| Use of monitoring and alert systems to identify risks and bottlenecks | |
| Availability of back up equipment for monitoring cold chain temperatures | |
| Strategies to reduce vaccine hesitancy | |
| Strategies for transferring technology | |
| Minimization of liability associated with technology use and licensure | |
| Establishment of regulatory training center | |
| Establishment of logistics training center | |
| Strategies to minimize waste | |
| Ability to trace vaccine waste resulting from criminal activity |